Biden cancels Trump-era epi-pen and insulin discount programs for low-income people

[marvin martian]

Trump hate trumps all in Biden's Amerika.

WH budget office approves Biden's plan to retract insulin, epipen discounts: report

The White House this week gave President Biden the greenlight to move forward with removing a Trump-era health care policy designed to bring down the price of insulin.

www.foxbusiness.com

The White House this week gave President Biden the greenlight to move forward with removing a Trump-era health care policy designed to bring down the price of insulin.

Biden’s bid to retract the rule was approved on Monday, as reported by Politico, with the expectation that the Department of Health and Human Services could publish the retraction within the coming days.

The measure, signed off on under the previous administration in December, aimed to require some 340B community health centers to deliver savings to low-income patients for insulin and epinephrine in a bid to bring down unaffordable prices.

Spokespeople for the White House and the Department of Health and Human Services did not return FOX Business’ request for comment.

The rule was scheduled to go into effect in January but was frozen at that time.

Earlier this year, the National Association of Health Care Centers said the rule would "adversely impact Community Health Centers" and make it harder for low-income patients to afford the medications.

 

[Osiris-ODS]

I'm sure the Democrat apologists will be rushing here any moment to brainstorm countless asinine rationalizations for this.

 

[Dekster]

Between the 500Million COVID doses to be exported and this, Big Pharma is having a profitable week under Joe.

 

[sartre play]

More information required. What's the other half of the story?

 

[EvilCat Breath]

I'm sure the Democrat apologists will be rushing here any moment to brainstorm countless asinine rationalizations for this.

White supremacy and racism.

 

[TNHarley]

Earlier this year, the National Association of Health Care Centers said the rule would "adversely impact Community Health Centers" and make it harder for low-income patients to afford the medications.

You misunderstood this statement. Fox left out context to rile people up.

Fact check: Biden administration delays implementation of Trump rule on insulin, EpiPens

The Trump executive order on the cost of insulin and EpiPens at community health centers isn't being reversed, as some claim. The rule is on hold.

www.usatoday.com

The National Association of Community Health Centers, among others, expressed support for the new administration's move, saying the Trump rule would not have lowered the cost of insulin and EpiPens for most Americans who use them, as advertised.

In a Jan. 25 statement, it also said the Trump rule reflected "a fundamental misunderstanding" of federally qualified health centers and the 340B drug program, placing extensive administrative burdens on them.

“The stated aim was to cut drug prices. However, it triggered alarm among safety net providers and bipartisan lawmakers because it would accomplish the opposite of what the Trump Administration intended — ultimately making it harder for health centers to provide affordable life-saving services and prescription drugs — especially during the pandemic,” the association said.

It pointed out that the only patients affected would be those using the health centers.

 

[L.K.Eder]

Trump hate trumps all in Biden's Amerika.

WH budget office approves Biden's plan to retract insulin, epipen discounts: report

The White House this week gave President Biden the greenlight to move forward with removing a Trump-era health care policy designed to bring down the price of insulin.

www.foxbusiness.com

The White House this week gave President Biden the greenlight to move forward with removing a Trump-era health care policy designed to bring down the price of insulin.

Biden’s bid to retract the rule was approved on Monday, as reported by Politico, with the expectation that the Department of Health and Human Services could publish the retraction within the coming days.

The measure, signed off on under the previous administration in December, aimed to require some 340B community health centers to deliver savings to low-income patients for insulin and epinephrine in a bid to bring down unaffordable prices.

Spokespeople for the White House and the Department of Health and Human Services did not return FOX Business’ request for comment.

The rule was scheduled to go into effect in January but was frozen at that time.

Earlier this year, the National Association of Health Care Centers said the rule would "adversely impact Community Health Centers" and make it harder for low-income patients to afford the medications.

nice bolded part shooting down your own "argument".